The Notre Dame MBA

MBA NEWS

Global Dosimetry Solutions, Inc. appoints Donald Naab as president

Donald Naab earned a MBA in 1985 from the University of Notre Dame

Publication: PR Newswire

August 29, 2006

Tags: Alumni, MBA

SAN FRANCISCO , Aug. 28 /PRNewswire/ -- Global Dosimetry Solutions, Inc. (GDS), a division of Mirion Technologies, today announced Donald Naab has been appointed President. Effective today, Mr. Naab fills the position held by Thomas Logan who was named Chairman and CEO of Mirion Technologies in January 2006. GDS provides dosimetry, consulting and system integration services for the nuclear and medical industries.

"We are thrilled that Don is joining GDS and Mirion," said Thomas Logan, Chairman and CEO of Mirion Technologies. "His style and experience make him ideally suited to extend the strong growth legacy of GDS."

"I am excited to join a company with a rich history of success and bright future," stated Naab, President of GDS. "Through the unparalleled caliber of our people, we will continue to provide unmatched service to our customers. We will build on our history focusing on key innovative industry solutions."

Most recently, Mr. Naab served as CEO of Sanders Industries. He is a seasoned leader with over 20 years experience in technology based companies ranging from the medical and defense markets to energy management. Don holds a Bachelor of Science degree in Electrical Engineering from the University of Wisconsin-Madison and a Masters of Business Administration degree from the University of Notre Dame. He is an active member of several associations including IEEE, ACG, and Vistage and is on the Board of OCEN.

ABOUT MIRION TECHNOLOGIES

Mirion Technologies generated approximately $150 million in revenue from its diverse global client base in 2005. The Company employs approximately 750 people worldwide, at its facilities in France, Germany, the United Kingdom, Finland, China, Canada and the United States. Mirion Technologies is headquartered in the San Francisco Bay area, and is a portfolio company of American Capital Strategies (Nasdaq: ACAS ).

###